EV/EBITDA
-6.23
-0.07-1.14%
Fri, 29 Nov 2024 21:38:14 GMT
Summary:
Travere Therapeutics EV/EBITDA is currently -6.23, with a fall of -0.07 (-1.14%) during the most recent trading day. Over the past year, it has dropped by -3.89 (-166.24%). TVTX EV/EBITDA is now -103.43% below its all-time high of 181.49.TVTX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TVTX EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | -1.1% |
| 3 m3 months | -86.0% |
| 6 m6 months | -157.4% |
| ytdytd | -98.4% |
| 1 y1 year | -166.2% |
| 5 y5 years | +28.2% |
TVTX EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | -5.64 | -10.5% | -6.41 | +2.8% |
| 3 m | 3 months | -3.35 | -86.0% | -6.41 | +2.8% |
| 6 m | 6 months | -2.42 | -157.4% | -6.41 | +2.8% |
| 1 y | 1 year | -2.11 | -195.3% | -6.41 | +2.8% |
| 3 y | 3 years | -2.05 | -203.9% | -15.32 | +59.3% |
| 5 y | 5 years | -2.05 | -203.9% | -26.18 | +76.2% |
| alltime | all time | 181.49 | -103.4% | -5339 | +99.9% |
Travere Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2024 | -6.23(+98.4%) |
| 2023 | -3.14(-60.4%) |
| 2022 | -7.93(-48.2%) |
| 2021 | -15.32(+40.4%) |
| 2020 | -10.91(+55.0%) |
| 2019 | -7.04(-50.8%) |
| Date | Value |
|---|---|
| 2018 | -14.31(-29.9%) |
| 2017 | -20.40(+3.9%) |
| 2016 | -19.64(-450.7%) |
| 2015 | 5.60(-130.3%) |
| 2014 | -18.48(+141.3%) |
| 2013 | -7.66(-99.7%) |
| 2012 | -2308.72 |
FAQ
- What is Travere Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Travere Therapeutics?
- What is TVTX EV/EBITDA year-to-date change?
- What is Travere Therapeutics EV/EBITDA year-on-year change?
What is Travere Therapeutics EV/EBITDA?
The current EV/EBITDA of TVTX is -6.23
What is the all time high EV/EBITDA for Travere Therapeutics?
Travere Therapeutics all-time high EV/EBITDA is 181.49
What is TVTX EV/EBITDA year-to-date change?
Travere Therapeutics EV/EBITDA has changed by -3.09 (-98.41%) since the beginning of the year
What is Travere Therapeutics EV/EBITDA year-on-year change?
Over the past year, TVTX EV/EBITDA has changed by -3.89 (-166.24%)